Jiangsu Hengrui Medicine Co., Ltd.
600276
शेयरों में रैंक
#544
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged... Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases, among others. The enterprise was founded in 1970 and maintains its corporate headquarters in Lianyungang, China.
शेयर मूल्य
$6.89
मार्केट कैप
$43.94B
बदलाव (1 दिन)
-2.91%
बदलाव (1 वर्ष)
-24.78%
देश
CN
व्यापार Jiangsu Hengrui Medicine Co., Ltd. (600276)
श्रेणी
Healthcare
Jiangsu Hengrui Medicine Co., Ltd. (600276) के लिए कमाई
2026 में कमाई TTM: 0
Jiangsu Hengrui Medicine Co., Ltd. की नवीनतम वित्तीय रिपोर्टों के अनुसार, कंपनी की वर्तमान कमाई 0 है। 2026 में कंपनी ने 0 की कमाई की, जो 2026 की कमाई 0 के के बराबर है। इस पृष्ठ पर दिखाई गई कमाई ब्याज और कर से पहले की कमाई है, जिसे EBIT कहा जाता है।
Jiangsu Hengrui Medicine Co., Ltd. के लिए कमाई का इतिहास 2001 से 2026 तक
प्रत्येक वर्ष के अंत में कमाई
| वर्ष | कमाई | परिवर्तन |
|---|---|---|
| 2025 | $1.24B | 26.71% |
| 2024 | $982.27M | 48.98% |
| 2023 | $659.33M | 14.60% |
| 2022 | $575.32M | -18.13% |
| 2021 | $702.70M | -33.43% |
| 2020 | $1.06B | 21.37% |
| 2019 | $869.67M | 32.96% |
| 2018 | $654.07M | 13.20% |
| 2017 | $577.79M | 33.13% |
| 2016 | $433.99M | 10.00% |
| 2015 | $394.53M | 35.79% |
| 2014 | $290.55M | 19.20% |
| 2013 | $243.75M | 12.88% |
| 2012 | $215.93M | 27.81% |
| 2011 | $168.94M | 29.63% |
| 2010 | $130.33M | 13.97% |
| 2009 | $114.35M | 66.01% |
| 2008 | $68.88M | -1.66% |
| 2007 | $70.05M | 89.01% |
| 2006 | $37.06M | 35.54% |
| 2005 | $27.34M | 31.05% |
| 2004 | $20.86M | 14.58% |
| 2003 | $18.21M | 36.38% |
| 2002 | $13.35M | 13.13% |
| 2001 | $11.80M | 0.00% |
समान कंपनियों या प्रतियोगियों की कमाई
| कंपनी | कमाई | कमाई में अंतर | देश |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | - |
IN
|
